Daihan Pharmaceutical Co.Ltd (023910) — Financial Flexibility Index
Daihan Pharmaceutical Co.Ltd (023910) has a Financial Flexibility Index of 0.40x as of September 2025. Free cash flow of ₩20.27 Billion (operating CF ₩9.47 Billion minus capex ₩10.79 Billion) represents 0% of total liabilities (₩50.75 Billion). Check total reinvestment intensity of Daihan Pharmaceutical Co.Ltd to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Daihan Pharmaceutical Co.Ltd Financial Flexibility Index (2014–2024)
Historical Financial Flexibility Index trend for Daihan Pharmaceutical Co.Ltd across 11 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Daihan Pharmaceutical Co.Ltd.
Annual Financial Flexibility Index for Daihan Pharmaceutical Co.Ltd (2014–2024)
Year-by-year free cash flow to debt coverage for Daihan Pharmaceutical Co.Ltd. Explore debt repayment capacity of Daihan Pharmaceutical Co.Ltd to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (KRW) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 1.06x | ₩51.44 Billion | ₩35.64 Billion | ₩48.42 Billion | ▼ -18.2% |
| 2023 | 1.30x | ₩60.14 Billion | ₩38.86 Billion | ₩46.28 Billion | ▲ +78.2% |
| 2022 | 0.73x | ₩37.62 Billion | ₩29.00 Billion | ₩51.58 Billion | ▼ -3.1% |
| 2021 | 0.75x | ₩52.47 Billion | ₩40.62 Billion | ₩69.73 Billion | ▲ +37.3% |
| 2020 | 0.55x | ₩38.99 Billion | ₩33.63 Billion | ₩71.17 Billion | ▼ -16.5% |
| 2019 | 0.66x | ₩52.57 Billion | ₩35.26 Billion | ₩80.08 Billion | ▼ -32.4% |
| 2018 | 0.97x | ₩91.63 Billion | ₩44.94 Billion | ₩94.39 Billion | ▲ +60.3% |
| 2017 | 0.61x | ₩41.50 Billion | ₩20.45 Billion | ₩68.52 Billion | ▼ -18.1% |
| 2016 | 0.74x | ₩49.82 Billion | ₩27.92 Billion | ₩67.36 Billion | ▲ +109.0% |
| 2015 | 0.35x | ₩21.94 Billion | ₩17.98 Billion | ₩61.99 Billion | ▲ +19.7% |
| 2014 | 0.30x | ₩19.95 Billion | ₩9.48 Billion | ₩67.52 Billion | — |